Visible node/edge number:
Node colors:
Node labels:

show label of nodes with degree >=

Node sizes:
Edge colors:
Edge widths factor:
Layout:

gravity >=

edgeLength =

GRN in network:

Notice: IE browser need to manually refresh (F5) this page after resetting the network.

This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.

"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.

miRNA-gene regulations

(Download full result)

Num microRNA           Gene miRNA log2FC miRNA pvalue Gene log2FC Gene pvalue Interaction Correlation beta Correlation P-value PMID Reported in cancer studies
1 hsa-miR-21-5p AKT2 1.51 0 -0.34 1.0E-5 miRNAWalker2 validate -0.25 0 NA
2 hsa-miR-330-5p AKT2 0.44 0.00533 -0.34 1.0E-5 miRanda -0.1 1.0E-5 NA
3 hsa-miR-342-3p AKT2 -0.32 0.04498 -0.34 1.0E-5 mirMAP -0.12 0 NA
4 hsa-miR-106b-5p AKT3 0.65 0 -0.66 0.00047 miRNATAP -0.26 0.00148 NA
5 hsa-miR-107 AKT3 0.24 0.01708 -0.66 0.00047 PITA; miRanda -0.6 0 NA
6 hsa-miR-122-5p AKT3 -1.24 0 -0.66 0.00047 miRNAWalker2 validate; miRTarBase -0.28 0 24244539 miR 122 regulates tumorigenesis in hepatocellular carcinoma by targeting AKT3; Here we identify AKT3 as a novel and direct target of miR-122; Restoration of miR-122 expression in HCC cell lines decreases AKT3 levels inhibits cell migration and proliferation and induces apoptosis; These anti-tumor phenotypes can be rescued by reconstitution of AKT3 expression indicating the essential role of AKT3 in miR-122 mediated HCC transformation; Our data strongly suggest that miR-122 is a tumor suppressor that targets AKT3 to regulate tumorigenesis in HCCs and a potential therapeutic candidate for liver cancer
7 hsa-miR-146b-5p AKT3 0.42 0.04574 -0.66 0.00047 miRNAWalker2 validate -0.16 0.00026 NA
8 hsa-miR-15a-5p AKT3 0.35 0.00077 -0.66 0.00047 miRNAWalker2 validate; miRTarBase; miRNATAP -0.27 0.00291 NA
9 hsa-miR-17-3p AKT3 0.41 0.00422 -0.66 0.00047 miRNATAP -0.35 0 NA
10 hsa-miR-17-5p AKT3 0.7 2.0E-5 -0.66 0.00047 TargetScan; miRNATAP -0.29 0 NA
11 hsa-miR-20a-5p AKT3 0.85 0 -0.66 0.00047 miRNATAP -0.29 0 NA
12 hsa-miR-32-3p AKT3 0.22 0.20722 -0.66 0.00047 mirMAP -0.23 4.0E-5 NA
13 hsa-miR-33a-3p AKT3 -0.68 1.0E-5 -0.66 0.00047 mirMAP -0.23 0.0001 NA
14 hsa-miR-362-3p AKT3 0.81 0 -0.66 0.00047 miRanda -0.22 0.00083 NA
15 hsa-miR-362-5p AKT3 0.72 2.0E-5 -0.66 0.00047 PITA; TargetScan; miRNATAP -0.15 0.00734 NA
16 hsa-miR-374a-5p AKT3 0.02 0.86978 -0.66 0.00047 mirMAP -0.28 0.00294 NA
17 hsa-miR-502-3p AKT3 0.66 0 -0.66 0.00047 miRNATAP -0.26 0.0008 NA
18 hsa-miR-616-5p AKT3 0.15 0.40284 -0.66 0.00047 mirMAP -0.2 0.0001 NA
19 hsa-miR-93-5p AKT3 1.4 0 -0.66 0.00047 miRNATAP -0.28 1.0E-5 NA
20 hsa-miR-330-5p BCL2L1 0.44 0.00533 0.02 0.82745 PITA; miRanda; miRNATAP -0.15 0 NA
21 hsa-miR-342-3p BCL2L1 -0.32 0.04498 0.02 0.82745 PITA; miRanda; miRNATAP -0.12 8.0E-5 NA
22 hsa-miR-342-5p BCL2L1 -0.78 0 0.02 0.82745 miRNATAP -0.11 0.00084 NA
23 hsa-miR-484 BCL2L1 0.09 0.45398 0.02 0.82745 miRNAWalker2 validate -0.21 0 NA
24 hsa-miR-192-5p CBL -0.5 0.00345 0.05 0.65471 mirMAP -0.24 0 NA
25 hsa-miR-22-3p CBL -0.63 0 0.05 0.65471 MirTarget -0.29 0 NA
26 hsa-miR-29c-3p CBL -1.44 0 0.05 0.65471 mirMAP -0.11 0.00382 NA
27 hsa-miR-618 CBL 0.14 0.51715 0.05 0.65471 mirMAP -0.12 4.0E-5 NA
28 hsa-miR-106a-5p CCND1 -0.46 0.00972 -0.9 1.0E-5 MirTarget; miRNATAP -0.26 0 NA
29 hsa-miR-106b-5p CCND1 0.65 0 -0.9 1.0E-5 miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP -0.43 0 NA
30 hsa-miR-1266-5p CCND1 1.63 0 -0.9 1.0E-5 MirTarget -0.23 0 NA
31 hsa-miR-15b-5p CCND1 0.23 0.08248 -0.9 1.0E-5 miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP -0.54 0 NA
32 hsa-miR-16-5p CCND1 -0.4 0.0001 -0.9 1.0E-5 miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP -0.31 0.00178 23991964; 22922827; 18483394 At the molecular level our results further revealed that cyclin D1 expression was negatively regulated by miR-16;CCND1 has been found to be a target of miR-15a and miR-16-1 through analysis of complementary sequences between microRNAs and CCND1 mRNA; Moreover the transcription of CCND1 is suppressed by miR-15a and miR-16-1 via direct binding to the CCND1 3'-untranslated region 3'-UTR;Truncation in CCND1 mRNA alters miR 16 1 regulation in mantle cell lymphoma; Furthermore we demonstrated that this truncation alters miR-16-1 binding sites and through the use of reporter constructs we were able to show that miR-16-1 regulates CCND1 mRNA expression; This study introduces the role of miR-16-1 in the regulation of CCND1 in MCL
33 hsa-miR-17-5p CCND1 0.7 2.0E-5 -0.9 1.0E-5 miRNAWalker2 validate; MirTarget; TargetScan; miRNATAP -0.34 0 26431674 Bioinformatics Prediction and In Vitro Analysis Revealed That miR 17 Targets Cyclin D1 mRNA in Triple Negative Breast Cancer Cells; In this study using bioinformatic analyses miR-17 was selected as it targets the 3'UTR of CCND1 gene with the highest score; After lentiviral transduction of miR-17 to the target cells gene expression analysis showed decreased expression of CCND1 gene
34 hsa-miR-186-5p CCND1 -0.06 0.53529 -0.9 1.0E-5 mirMAP -0.32 0.00286 NA
35 hsa-miR-19a-3p CCND1 1.02 0 -0.9 1.0E-5 miRNAWalker2 validate; miRTarBase; miRNATAP -0.28 0 25985117 Moreover miR-19a might play inhibitory roles in HCC malignancy via regulating Cyclin D1 expression
36 hsa-miR-19b-1-5p CCND1 -0.28 0.07831 -0.9 1.0E-5 miRNAWalker2 validate; miRTarBase -0.31 0 NA
37 hsa-miR-19b-3p CCND1 0.6 0.00017 -0.9 1.0E-5 miRNATAP -0.34 0 NA
38 hsa-miR-20a-5p CCND1 0.85 0 -0.9 1.0E-5 miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP -0.33 0 NA
39 hsa-miR-20b-5p CCND1 0.46 0.02859 -0.9 1.0E-5 MirTarget; miRNATAP -0.23 0 NA
40 hsa-miR-340-5p CCND1 -0 0.9685 -0.9 1.0E-5 mirMAP -0.32 0.00013 NA
41 hsa-miR-425-5p CCND1 0.59 2.0E-5 -0.9 1.0E-5 miRNAWalker2 validate -0.39 0 NA
42 hsa-miR-503-5p CCND1 0.19 0.26842 -0.9 1.0E-5 miRNAWalker2 validate; miRTarBase; MirTarget -0.16 0.00815 26047605; 23731275 MiR 503 inhibited cell proliferation of human breast cancer cells by suppressing CCND1 expression; Overexpression of miR-503 in breast cancer cell lines reduced cell proliferation through inducing G0/G1 cell cycle arrest by targeting CCND1;MicroRNA 503 suppresses proliferation and cell cycle progression of endometrioid endometrial cancer by negatively regulating cyclin D1; CCND1 has a binding sequence of miR-503 within its 3' untranslated region and was confirmed to be a direct target of miR-503 by the fluorescent reporter assays; Increasing the miR-503 level in EEC cells suppressed cell viability colon formation activity and cell-cycle progression and the inhibited oncogenic phenotypes induced by miR-503 were alleviated by ectopic expression of CCND1 without the untranslated region sequence; Collectively this study suggested that miR-503 plays a tumor-suppressor role by targeting CCND1; Abnormal suppression of miR-503 leads to an increase in the CCND1 level which may promote carcinogenesis and progression of EEC
43 hsa-miR-589-3p CCND1 1.17 0 -0.9 1.0E-5 MirTarget -0.18 0.00124 NA
44 hsa-miR-616-5p CCND1 0.15 0.40284 -0.9 1.0E-5 mirMAP -0.26 1.0E-5 NA
45 hsa-miR-7-1-3p CCND1 -0.57 2.0E-5 -0.9 1.0E-5 mirMAP -0.26 0.00057 NA
46 hsa-miR-9-5p CCND1 1.26 9.0E-5 -0.9 1.0E-5 miRNAWalker2 validate -0.14 1.0E-5 NA
47 hsa-miR-92a-3p CCND1 0.21 0.13429 -0.9 1.0E-5 miRNAWalker2 validate -0.41 0 NA
48 hsa-miR-93-5p CCND1 1.4 0 -0.9 1.0E-5 miRNAWalker2 validate; MirTarget; miRNATAP -0.34 0 NA
49 hsa-miR-942-5p CCND1 0.35 0.02833 -0.9 1.0E-5 MirTarget -0.25 0.00012 NA
50 hsa-miR-130b-5p CCND2 0.17 0.33761 0.36 0.03656 mirMAP -0.17 0.00018 NA
51 hsa-miR-20a-5p CCND2 0.85 0 0.36 0.03656 miRNAWalker2 validate; miRTarBase; miRNATAP -0.16 0.00121 NA
52 hsa-miR-28-5p CCND2 -0.43 0 0.36 0.03656 miRanda -0.48 0 NA
53 hsa-miR-33a-3p CCND2 -0.68 1.0E-5 0.36 0.03656 MirTarget -0.26 0 NA
54 hsa-miR-3607-3p CCND2 -2.16 0 0.36 0.03656 mirMAP -0.12 0.0007 NA
55 hsa-miR-378a-3p CCND2 -1.19 0 0.36 0.03656 miRNAWalker2 validate -0.18 2.0E-5 NA
56 hsa-miR-548v CCND2 -0.27 0.17626 0.36 0.03656 MirTarget -0.15 0.00034 NA
57 hsa-miR-616-5p CCND2 0.15 0.40284 0.36 0.03656 mirMAP -0.32 0 NA
58 hsa-miR-618 CCND2 0.14 0.51715 0.36 0.03656 mirMAP -0.23 0 NA
59 hsa-miR-27b-3p CCND3 -0.82 0 0.08 0.47843 miRNAWalker2 validate -0.24 0 NA
60 hsa-miR-320a CCND3 0.33 0.02214 0.08 0.47843 miRanda -0.12 0.00135 NA
61 hsa-miR-324-5p CISH 0.37 0.00592 -1.22 0 miRanda -0.22 0.00106 NA
62 hsa-miR-21-5p CNTFR 1.51 0 -3.51 0 miRNATAP -1.1 0 NA
63 hsa-miR-589-5p CNTFR 1.19 0 -3.51 0 miRNATAP -0.73 0.00049 NA
64 hsa-miR-324-3p CREBBP 0.26 0.05061 -0.2 0.01387 miRNAWalker2 validate -0.12 3.0E-5 NA
65 hsa-miR-330-5p CREBBP 0.44 0.00533 -0.2 0.01387 miRanda -0.11 1.0E-5 NA
66 hsa-miR-769-5p CREBBP 0.22 0.03334 -0.2 0.01387 miRNAWalker2 validate -0.13 0.00077 NA
67 hsa-miR-19a-3p CSF2RB 1.02 0 -0.51 0.00683 MirTarget -0.12 0.00885 NA
68 hsa-miR-19b-3p CSF2RB 0.6 0.00017 -0.51 0.00683 MirTarget -0.15 0.00713 NA
69 hsa-miR-204-5p CSF2RB -0.54 0.03309 -0.51 0.00683 MirTarget -0.11 0.00224 NA
70 hsa-miR-30b-3p CSF2RB -0.44 0.00095 -0.51 0.00683 MirTarget -0.2 0.00366 NA
71 hsa-miR-455-5p CSF2RB -0.27 0.05813 -0.51 0.00683 miRanda -0.37 0 NA
72 hsa-miR-532-5p CSF2RB 1.03 0 -0.51 0.00683 MirTarget -0.33 0 NA
73 hsa-miR-339-5p EP300 0.28 0.03557 -0.2 0.07049 miRanda -0.16 0.0001 NA
74 hsa-miR-342-3p EP300 -0.32 0.04498 -0.2 0.07049 MirTarget; PITA; miRanda; miRNATAP -0.11 0.00085 NA
75 hsa-let-7e-5p GHR 0.04 0.81107 -3.07 0 miRNATAP -0.38 0.00015 NA
76 hsa-miR-15a-5p GHR 0.35 0.00077 -3.07 0 MirTarget; miRNATAP -0.55 8.0E-5 NA
77 hsa-miR-29a-5p GHR -0.11 0.34962 -3.07 0 mirMAP; miRNATAP -0.36 0.00254 NA
78 hsa-miR-361-5p GHR 0.23 0.00962 -3.07 0 miRanda -0.69 2.0E-5 NA
79 hsa-miR-421 GHR 0.94 0 -3.07 0 miRanda -0.76 0 NA
80 hsa-miR-361-5p IFNAR1 0.23 0.00962 -0.79 0 miRanda -0.16 0.00059 NA
81 hsa-miR-3913-5p IFNAR1 0.25 0.0628 -0.79 0 mirMAP -0.13 4.0E-5 NA
82 hsa-miR-181b-5p IFNGR1 0.49 0.00105 -0.36 0.01168 miRNAWalker2 validate -0.27 0 NA
83 hsa-miR-362-3p IFNGR1 0.81 0 -0.36 0.01168 miRanda -0.13 0.00937 NA
84 hsa-miR-26b-5p IFNGR2 -1.11 0 0.13 0.22292 miRNAWalker2 validate -0.13 0.00238 NA
85 hsa-miR-455-5p IL10RA -0.27 0.05813 -0.99 0 miRanda -0.3 0 NA
86 hsa-miR-326 IL11RA -1.88 0 0.13 0.31327 miRanda -0.11 0.00029 NA
87 hsa-miR-330-5p IL11RA 0.44 0.00533 0.13 0.31327 miRanda -0.19 0 NA
88 hsa-miR-455-5p IL12RB1 -0.27 0.05813 -0.72 0.00084 miRanda -0.34 1.0E-5 NA
89 hsa-miR-338-3p IL12RB2 0.54 0.00461 -0.41 0.10321 miRanda -0.2 0.0024 NA
90 hsa-miR-128-3p IL13RA1 0.29 0.01144 -0.7 0 MirTarget -0.13 0.00645 NA
91 hsa-miR-16-2-3p IL13RA1 -0.03 0.80516 -0.7 0 MirTarget -0.19 0 NA
92 hsa-miR-181a-2-3p IL13RA1 -0.23 0.2364 -0.7 0 MirTarget -0.15 0 NA
93 hsa-miR-185-5p IL13RA1 0.48 0 -0.7 0 MirTarget -0.15 0.00899 NA
94 hsa-miR-188-5p IL13RA1 1.12 0 -0.7 0 MirTarget; miRNATAP -0.16 0 NA
95 hsa-miR-324-5p IL13RA1 0.37 0.00592 -0.7 0 miRanda -0.21 0 NA
96 hsa-miR-330-3p IL13RA1 -0.33 0.03161 -0.7 0 MirTarget; PITA; miRNATAP -0.13 0.0003 NA
97 hsa-miR-331-3p IL13RA1 -0.28 0.03738 -0.7 0 MirTarget -0.13 0.0009 NA
98 hsa-miR-331-5p IL13RA1 0.21 0.12077 -0.7 0 miRNATAP -0.24 0 NA
99 hsa-miR-338-5p IL13RA1 -0.22 0.25239 -0.7 0 MirTarget; PITA -0.13 1.0E-5 NA
100 hsa-miR-421 IL13RA1 0.94 0 -0.7 0 miRanda -0.12 0.00012 NA
101 hsa-miR-148b-3p IL13RA2 0.27 0.00185 -4.49 0 miRNAWalker2 validate -0.8 0.00077 NA
102 hsa-miR-107 IL15 0.24 0.01708 -0.3 0.13357 miRanda; miRNATAP -0.56 0 NA
103 hsa-miR-148a-3p IL15 -0.75 0 -0.3 0.13357 MirTarget -0.36 0 NA
104 hsa-miR-192-5p IL15 -0.5 0.00345 -0.3 0.13357 miRNAWalker2 validate -0.31 0 NA
105 hsa-miR-19a-3p IL15 1.02 0 -0.3 0.13357 MirTarget -0.17 0.00047 NA
106 hsa-miR-19b-3p IL15 0.6 0.00017 -0.3 0.13357 MirTarget -0.25 4.0E-5 NA
107 hsa-miR-374a-5p IL20RA 0.02 0.86978 -3.19 0 mirMAP -0.85 0.00024 NA
108 hsa-miR-374b-5p IL20RA -0.31 0.00301 -3.19 0 mirMAP -0.64 0.00422 NA
109 hsa-miR-664a-3p IL20RA 0.49 0.00073 -3.19 0 MirTarget; mirMAP -0.53 0.00091 NA
110 hsa-miR-107 IL6 0.24 0.01708 -2.01 0 miRanda -0.96 0 NA
111 hsa-miR-361-5p IL6 0.23 0.00962 -2.01 0 miRanda -0.75 6.0E-5 NA
112 hsa-miR-365a-3p IL6 0.16 0.15325 -2.01 0 miRNAWalker2 validate -0.51 0.00048 NA
113 hsa-let-7e-5p IL6R 0.04 0.81107 -0.2 0.38255 miRNATAP -0.31 3.0E-5 NA
114 hsa-let-7i-5p IL6R -0.14 0.15414 -0.2 0.38255 miRNATAP -0.44 6.0E-5 NA
115 hsa-miR-103a-2-5p IL6R 1.17 0 -0.2 0.38255 mirMAP -0.15 0.00673 NA
116 hsa-miR-125a-5p IL6R -0.91 0 -0.2 0.38255 MirTarget; miRanda -0.24 0.00014 NA
117 hsa-miR-130a-3p IL6R -1.53 0 -0.2 0.38255 mirMAP -0.2 0.00111 NA
118 hsa-miR-141-3p IL6R -0.35 0.257 -0.2 0.38255 MirTarget -0.14 5.0E-5 NA
119 hsa-miR-141-5p IL6R -0.5 0.10265 -0.2 0.38255 MirTarget -0.12 0.0014 NA
120 hsa-miR-155-5p IL6R 0.01 0.95651 -0.2 0.38255 MirTarget -0.28 0 NA
121 hsa-miR-182-5p IL6R 1.97 0 -0.2 0.38255 mirMAP -0.14 1.0E-5 NA
122 hsa-miR-200a-3p IL6R -1.5 3.0E-5 -0.2 0.38255 MirTarget -0.16 0 NA
123 hsa-miR-21-5p IL6R 1.51 0 -0.2 0.38255 MirTarget; miRNATAP -0.54 0 NA
124 hsa-miR-23a-3p IL6R -0.18 0.13598 -0.2 0.38255 miRNAWalker2 validate; miRTarBase; MirTarget -0.48 0 NA
125 hsa-miR-301a-3p IL6R 0.84 0 -0.2 0.38255 mirMAP -0.27 1.0E-5 NA
126 hsa-miR-30b-5p IL6R -0.54 2.0E-5 -0.2 0.38255 mirMAP -0.34 6.0E-5 NA
127 hsa-miR-330-3p IL6R -0.33 0.03161 -0.2 0.38255 miRNATAP -0.4 0 NA
128 hsa-miR-331-3p IL6R -0.28 0.03738 -0.2 0.38255 MirTarget -0.27 0.00073 NA
129 hsa-miR-421 IL6R 0.94 0 -0.2 0.38255 mirMAP -0.18 0.0031 NA
130 hsa-miR-501-5p IL6R 1.15 0 -0.2 0.38255 miRNATAP -0.18 0.00194 NA
131 hsa-miR-103a-3p IL6ST 0.77 0 -1.92 0 mirMAP -0.67 1.0E-5 NA
132 hsa-miR-1301-3p IL6ST 1.12 0 -1.92 0 MirTarget -0.34 0.00023 NA
133 hsa-miR-130b-3p IL6ST 0.69 0.00011 -1.92 0 miRNATAP -0.29 0.00192 NA
134 hsa-miR-148b-5p IL6ST 0.3 0.02557 -1.92 0 mirMAP -0.44 0.00054 NA
135 hsa-miR-16-1-3p IL6ST 0.39 0.00112 -1.92 0 mirMAP -0.38 0.00651 NA
136 hsa-miR-17-5p IL6ST 0.7 2.0E-5 -1.92 0 TargetScan -0.54 0 NA
137 hsa-miR-181b-5p IL6ST 0.49 0.00105 -1.92 0 mirMAP -0.3 0.00837 NA
138 hsa-miR-19a-3p IL6ST 1.02 0 -1.92 0 mirMAP; miRNATAP -0.33 8.0E-5 NA
139 hsa-miR-19b-3p IL6ST 0.6 0.00017 -1.92 0 mirMAP; miRNATAP -0.38 0.00032 NA
140 hsa-miR-21-5p IL6ST 1.51 0 -1.92 0 mirMAP -0.64 0 NA
141 hsa-miR-301a-3p IL6ST 0.84 0 -1.92 0 mirMAP; miRNATAP -0.52 0 NA
142 hsa-miR-32-3p IL6ST 0.22 0.20722 -1.92 0 mirMAP -0.27 0.00761 NA
143 hsa-miR-362-3p IL6ST 0.81 0 -1.92 0 PITA; miRanda; miRNATAP -0.37 0.0023 NA
144 hsa-miR-362-5p IL6ST 0.72 2.0E-5 -1.92 0 mirMAP -0.37 0.00018 NA
145 hsa-miR-421 IL6ST 0.94 0 -1.92 0 PITA; miRanda; mirMAP -0.32 0.00069 NA
146 hsa-miR-452-5p IL6ST 1.92 0 -1.92 0 mirMAP -0.22 0.00064 NA
147 hsa-miR-455-5p IL6ST -0.27 0.05813 -1.92 0 miRanda -0.38 0.00126 NA
148 hsa-miR-501-5p IL6ST 1.15 0 -1.92 0 mirMAP -0.39 1.0E-5 NA
149 hsa-miR-532-5p IL6ST 1.03 0 -1.92 0 PITA -0.59 0 NA
150 hsa-miR-589-3p IL6ST 1.17 0 -1.92 0 mirMAP -0.38 5.0E-5 NA

Over-represented Gene Ontology Biological Process

NumGOOverlapSizeP ValueAdj. P Value
1 CYTOKINE MEDIATED SIGNALING PATHWAY 35 452 3.613e-39 8.675e-36
2 CELLULAR RESPONSE TO ORGANIC SUBSTANCE 52 1848 3.729e-39 8.675e-36
3 RESPONSE TO CYTOKINE 38 714 1.134e-36 1.759e-33
4 CELLULAR RESPONSE TO CYTOKINE STIMULUS 35 606 1.121e-34 1.305e-31
5 STAT CASCADE 14 50 8.816e-24 6.837e-21
6 JAK STAT CASCADE 14 50 8.816e-24 6.837e-21
7 REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 35 1656 6.129e-20 4.074e-17
8 INTRACELLULAR SIGNAL TRANSDUCTION 34 1572 1.326e-19 7.713e-17
9 REGULATION OF PHOSPHORUS METABOLIC PROCESS 34 1618 3.275e-19 1.693e-16
10 REGULATION OF IMMUNE RESPONSE 26 858 3.555e-18 1.654e-15
11 REGULATION OF KINASE ACTIVITY 25 776 4.448e-18 1.881e-15
12 POSITIVE REGULATION OF RESPONSE TO STIMULUS 35 1929 8.105e-18 3.143e-15
13 REGULATION OF PROTEIN MODIFICATION PROCESS 33 1710 1.849e-17 6.616e-15
14 REGULATION OF JAK STAT CASCADE 14 144 7.23e-17 2.103e-14
15 REGULATION OF IMMUNE SYSTEM PROCESS 30 1403 6.345e-17 2.103e-14
16 REGULATION OF STAT CASCADE 14 144 7.23e-17 2.103e-14
17 REGULATION OF TRANSFERASE ACTIVITY 25 946 4.606e-16 1.261e-13
18 ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY 22 689 8.579e-16 2.218e-13
19 RESPONSE TO HORMONE 24 893 1.444e-15 3.537e-13
20 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY 19 498 4.711e-15 1.096e-12
21 RESPONSE TO ENDOGENOUS STIMULUS 28 1450 1.357e-14 3.006e-12
22 CELLULAR RESPONSE TO ENDOGENOUS STIMULUS 24 1008 2.102e-14 4.446e-12
23 CELLULAR RESPONSE TO HORMONE STIMULUS 19 552 3.015e-14 5.846e-12
24 REGULATION OF TYROSINE PHOSPHORYLATION OF STAT3 PROTEIN 9 44 2.973e-14 5.846e-12
25 RESPONSE TO PEPTIDE 17 404 3.291e-14 6.125e-12
26 PHOSPHORYLATION 25 1228 1.776e-13 3.178e-11
27 RESPONSE TO OXYGEN CONTAINING COMPOUND 26 1381 3.029e-13 5.22e-11
28 CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS 7 20 3.534e-13 5.872e-11
29 REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS 9 59 5.057e-13 8.113e-11
30 POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT3 PROTEIN 8 37 5.306e-13 8.23e-11
31 REGULATION OF RESPONSE TO INTERFERON GAMMA 7 22 7.732e-13 1.16e-10
32 RESPONSE TO NITROGEN COMPOUND 21 859 8.074e-13 1.174e-10
33 CELLULAR RESPONSE TO NITROGEN COMPOUND 17 505 1.21e-12 1.656e-10
34 POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 21 876 1.175e-12 1.656e-10
35 REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN 9 68 1.935e-12 2.572e-10
36 CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND 20 799 2.084e-12 2.693e-10
37 REGULATION OF RESPONSE TO CYTOKINE STIMULUS 11 144 2.756e-12 3.466e-10
38 POSITIVE REGULATION OF STAT CASCADE 9 73 3.759e-12 4.485e-10
39 POSITIVE REGULATION OF JAK STAT CASCADE 9 73 3.759e-12 4.485e-10
40 IMMUNE SYSTEM PROCESS 29 1984 4.556e-12 5.3e-10
41 NEGATIVE REGULATION OF CELL COMMUNICATION 23 1192 6.613e-12 7.504e-10
42 CELL ACTIVATION 17 568 7.835e-12 8.68e-10
43 RESPONSE TO GROWTH HORMONE 7 30 9.028e-12 9.769e-10
44 REGULATION OF CELL DEATH 25 1472 9.789e-12 1.035e-09
45 NEGATIVE REGULATION OF CELL DEATH 20 872 1.02e-11 1.055e-09
46 CELLULAR RESPONSE TO PEPTIDE 13 274 1.067e-11 1.079e-09
47 POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS 25 1492 1.313e-11 1.275e-09
48 NEGATIVE REGULATION OF RESPONSE TO STIMULUS 24 1360 1.316e-11 1.275e-09
49 NEGATIVE REGULATION OF PHOSPHORYLATION 15 422 1.43e-11 1.358e-09
50 POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS 22 1135 1.983e-11 1.845e-09
51 NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 15 437 2.342e-11 2.137e-09
52 PROTEIN PHOSPHORYLATION 20 944 4.243e-11 3.796e-09
53 REGULATION OF DEFENSE RESPONSE 18 759 7.942e-11 6.972e-09
54 POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS 19 867 8.183e-11 7.051e-09
55 REGULATION OF CELL PROLIFERATION 24 1496 9.581e-11 8.106e-09
56 POSITIVE REGULATION OF CELL COMMUNICATION 24 1532 1.564e-10 1.299e-08
57 LYMPHOCYTE ACTIVATION 13 342 1.682e-10 1.373e-08
58 REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION 11 213 1.927e-10 1.546e-08
59 POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 20 1036 2.208e-10 1.712e-08
60 POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 20 1036 2.208e-10 1.712e-08
61 POSITIVE REGULATION OF CELL PROLIFERATION 18 814 2.466e-10 1.881e-08
62 REGULATION OF INNATE IMMUNE RESPONSE 13 357 2.851e-10 2.14e-08
63 POSITIVE REGULATION OF GLUCOSE IMPORT IN RESPONSE TO INSULIN STIMULUS 5 12 3.529e-10 2.606e-08
64 PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS 7 49 3.614e-10 2.628e-08
65 REGULATION OF RESPONSE TO STRESS 23 1468 4.28e-10 3.064e-08
66 NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 15 541 4.593e-10 3.19e-08
67 NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 15 541 4.593e-10 3.19e-08
68 PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS 26 1977 9.333e-10 6.294e-08
69 PEPTIDYL TYROSINE MODIFICATION 10 186 9.292e-10 6.294e-08
70 NEGATIVE REGULATION OF KINASE ACTIVITY 11 250 1.055e-09 7.015e-08
71 JAK STAT CASCADE INVOLVED IN GROWTH HORMONE SIGNALING PATHWAY 5 15 1.327e-09 8.697e-08
72 LEUKOCYTE ACTIVATION 13 414 1.731e-09 1.118e-07
73 REGULATION OF GLUCOSE IMPORT IN RESPONSE TO INSULIN STIMULUS 5 17 2.72e-09 1.71e-07
74 NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS 15 616 2.707e-09 1.71e-07
75 LYMPHOCYTE DIFFERENTIATION 10 209 2.877e-09 1.785e-07
76 PEPTIDYL AMINO ACID MODIFICATION 17 841 3.315e-09 2.03e-07
77 NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS 19 1087 3.59e-09 2.169e-07
78 RESPONSE TO ALCOHOL 12 362 4.272e-09 2.548e-07
79 POSITIVE REGULATION OF CYTOKINE PRODUCTION 12 370 5.456e-09 3.214e-07
80 REGULATION OF CYTOKINE PRODUCTION 14 563 7.581e-09 4.355e-07
81 POSITIVE REGULATION OF IMMUNE RESPONSE 14 563 7.581e-09 4.355e-07
82 REGULATION OF LEUKOCYTE DIFFERENTIATION 10 232 7.844e-09 4.451e-07
83 REGULATION OF HOMOTYPIC CELL CELL ADHESION 11 307 9.021e-09 5.057e-07
84 PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS 8 120 9.182e-09 5.079e-07
85 NEGATIVE REGULATION OF JAK STAT CASCADE 6 44 9.388e-09 5.079e-07
86 NEGATIVE REGULATION OF STAT CASCADE 6 44 9.388e-09 5.079e-07
87 POSITIVE REGULATION OF CELL ACTIVATION 11 311 1.031e-08 5.516e-07
88 REGULATION OF CELL ACTIVATION 13 484 1.123e-08 5.94e-07
89 IMMUNE EFFECTOR PROCESS 13 486 1.18e-08 6.167e-07
90 RESPONSE TO ORGANIC CYCLIC COMPOUND 17 917 1.201e-08 6.206e-07
91 INSULIN RECEPTOR SIGNALING PATHWAY 7 80 1.227e-08 6.206e-07
92 POSITIVE REGULATION OF CELL CELL ADHESION 10 243 1.22e-08 6.206e-07
93 POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS 5 23 1.455e-08 7.281e-07
94 LEUKOCYTE CELL CELL ADHESION 10 255 1.929e-08 9.55e-07
95 POSITIVE REGULATION OF MOLECULAR FUNCTION 23 1791 1.956e-08 9.579e-07
96 LEUKOCYTE MIGRATION 10 259 2.236e-08 1.084e-06
97 PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 5 25 2.285e-08 1.096e-06
98 NEGATIVE REGULATION OF TRANSFERASE ACTIVITY 11 351 3.572e-08 1.696e-06
99 RESPONSE TO INSULIN 9 205 3.968e-08 1.865e-06
100 RESPONSE TO LIPID 16 888 5.197e-08 2.418e-06
101 LIPID PHOSPHORYLATION 7 99 5.456e-08 2.514e-06
102 LEUKOCYTE DIFFERENTIATION 10 292 6.912e-08 3.153e-06
103 REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 12 470 7.63e-08 3.447e-06
104 REGULATION OF CELL CELL ADHESION 11 380 7.998e-08 3.578e-06
105 REGULATION OF T CELL DIFFERENTIATION 7 107 9.349e-08 4.143e-06
106 POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION 8 162 9.604e-08 4.216e-06
107 REGULATION OF CELL DIFFERENTIATION 20 1492 1.093e-07 4.753e-06
108 NEGATIVE REGULATION OF MOLECULAR FUNCTION 17 1079 1.28e-07 5.513e-06
109 RESPONSE TO EXTERNAL STIMULUS 22 1821 1.309e-07 5.589e-06
110 GLUCOSE HOMEOSTASIS 8 170 1.393e-07 5.736e-06
111 REGULATION OF HEMOPOIESIS 10 314 1.36e-07 5.736e-06
112 NEGATIVE REGULATION OF CATALYTIC ACTIVITY 15 829 1.384e-07 5.736e-06
113 CARBOHYDRATE HOMEOSTASIS 8 170 1.393e-07 5.736e-06
114 POSITIVE REGULATION OF CATALYTIC ACTIVITY 20 1518 1.449e-07 5.912e-06
115 IMMUNE RESPONSE 17 1100 1.685e-07 6.817e-06
116 POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 19 1395 1.938e-07 7.774e-06
117 REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY 5 39 2.384e-07 9.402e-06
118 REGULATION OF CELL ADHESION 13 629 2.38e-07 9.402e-06
119 T CELL DIFFERENTIATION 7 123 2.436e-07 9.526e-06
120 REGULATION OF GROWTH 13 633 2.558e-07 9.902e-06
121 INOSITOL LIPID MEDIATED SIGNALING 7 124 2.575e-07 9.902e-06
122 POSITIVE REGULATION OF GLUCOSE TRANSPORT 5 42 3.494e-07 1.333e-05
123 PHOSPHATIDYLINOSITOL METABOLIC PROCESS 8 193 3.681e-07 1.393e-05
124 REGULATION OF LYMPHOCYTE DIFFERENTIATION 7 132 3.943e-07 1.48e-05
125 REGULATION OF MAPK CASCADE 13 660 4.114e-07 1.531e-05
126 NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY 5 44 4.437e-07 1.638e-05
127 REGULATION OF ERBB SIGNALING PATHWAY 6 83 4.51e-07 1.652e-05
128 POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION 7 136 4.83e-07 1.756e-05
129 SINGLE ORGANISM CELL ADHESION 11 459 5.277e-07 1.903e-05
130 REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 7 138 5.332e-07 1.909e-05
131 REGULATION OF LEUKOCYTE PROLIFERATION 8 206 6.039e-07 2.145e-05
132 POSITIVE REGULATION OF CELL ADHESION 10 376 7.121e-07 2.51e-05
133 POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 9 289 7.293e-07 2.533e-05
134 GLYCEROLIPID BIOSYNTHETIC PROCESS 8 211 7.239e-07 2.533e-05
135 NEGATIVE REGULATION OF MAPK CASCADE 7 145 7.451e-07 2.568e-05
136 RESPONSE TO ESTRADIOL 7 146 7.805e-07 2.651e-05
137 CELLULAR RESPONSE TO INSULIN STIMULUS 7 146 7.805e-07 2.651e-05
138 REGULATION OF T CELL PROLIFERATION 7 147 8.173e-07 2.756e-05
139 POSITIVE REGULATION OF KINASE ACTIVITY 11 482 8.533e-07 2.856e-05
140 RESPONSE TO ESTROGEN 8 218 9.259e-07 3.077e-05
141 CELL MOTILITY 14 835 9.612e-07 3.128e-05
142 LOCALIZATION OF CELL 14 835 9.612e-07 3.128e-05
143 CELLULAR RESPONSE TO INTERLEUKIN 6 4 22 9.596e-07 3.128e-05
144 POSITIVE REGULATION OF T CELL PROLIFERATION 6 95 1.005e-06 3.247e-05
145 RESPONSE TO STEROID HORMONE 11 497 1.151e-06 3.694e-05
146 CELL CELL ADHESION 12 608 1.189e-06 3.788e-05
147 POSITIVE REGULATION OF GENE EXPRESSION 20 1733 1.202e-06 3.804e-05
148 EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 5 55 1.379e-06 4.337e-05
149 POSITIVE REGULATION OF DEVELOPMENTAL PROCESS 16 1142 1.533e-06 4.786e-05
150 PHOSPHOLIPID BIOSYNTHETIC PROCESS 8 235 1.626e-06 5.045e-05
151 FAT CELL DIFFERENTIATION 6 106 1.914e-06 5.897e-05
152 RESPONSE TO INTERLEUKIN 6 4 26 1.941e-06 5.902e-05
153 RESPONSE TO BIOTIC STIMULUS 14 886 1.934e-06 5.902e-05
154 REGULATION OF GLUCOSE IMPORT 5 60 2.137e-06 6.456e-05
155 RESPONSE TO VIRUS 8 247 2.357e-06 7.076e-05
156 REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT 19 1672 3.02e-06 9.008e-05
157 CELL PROLIFERATION 12 672 3.352e-06 9.935e-05
158 RESPONSE TO KETONE 7 182 3.404e-06 0.0001002
159 REGULATION OF MULTICELLULAR ORGANISM GROWTH 5 66 3.44e-06 0.0001007
160 RESPONSE TO TYPE I INTERFERON 5 68 3.991e-06 0.0001161
161 NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS 4 31 4.031e-06 0.0001165
162 CELLULAR RESPONSE TO INTERFERON GAMMA 6 122 4.34e-06 0.0001246
163 INTERFERON GAMMA MEDIATED SIGNALING PATHWAY 5 70 4.608e-06 0.0001316
164 TYROSINE PHOSPHORYLATION OF STAT PROTEIN 3 10 4.841e-06 0.0001374
165 IMMUNE SYSTEM DEVELOPMENT 11 582 5.262e-06 0.0001484
166 POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION 6 131 6.546e-06 0.0001835
167 POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY 4 36 7.447e-06 0.0002075
168 ERBB SIGNALING PATHWAY 5 79 8.375e-06 0.000232
169 LIPID MODIFICATION 7 210 8.715e-06 0.0002399
170 NATURAL KILLER CELL DIFFERENTIATION 3 12 8.831e-06 0.0002417
171 POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION 5 80 8.909e-06 0.0002424
172 POSITIVE REGULATION OF TRANSFERASE ACTIVITY 11 616 8.997e-06 0.0002434
173 GLYCEROPHOSPHOLIPID METABOLIC PROCESS 8 297 9.146e-06 0.000246
174 PLATELET ACTIVATION 6 142 1.04e-05 0.0002781
175 ORGAN REGENERATION 5 83 1.067e-05 0.0002838
176 RESPONSE TO INTERFERON GAMMA 6 144 1.126e-05 0.0002978
177 REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 4 40 1.143e-05 0.0002994
178 ENERGY HOMEOSTASIS 3 13 1.145e-05 0.0002994
179 HOMEOSTATIC PROCESS 16 1337 1.153e-05 0.0002998
180 POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION 5 88 1.421e-05 0.0003673
181 REGULATION OF MAP KINASE ACTIVITY 8 319 1.534e-05 0.0003901
182 REGULATION OF INSULIN RECEPTOR SIGNALING PATHWAY 4 43 1.532e-05 0.0003901
183 ACUTE PHASE RESPONSE 4 43 1.532e-05 0.0003901
184 IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY 8 323 1.678e-05 0.0004244
185 NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION 3 15 1.813e-05 0.0004535
186 T CELL LINEAGE COMMITMENT 3 15 1.813e-05 0.0004535
187 DEFENSE RESPONSE 15 1231 1.851e-05 0.0004606
188 POSITIVE REGULATION OF CELL CYCLE 8 332 2.045e-05 0.000506
189 REGULATION OF CELL CYCLE 13 949 2.185e-05 0.0005379
190 REGULATION OF TYROSINE PHOSPHORYLATION OF STAT1 PROTEIN 3 16 2.225e-05 0.000545
191 POSITIVE REGULATION OF HEMOPOIESIS 6 163 2.277e-05 0.0005548
192 REGULATION OF LIPID KINASE ACTIVITY 4 48 2.383e-05 0.0005776
193 LOCOMOTION 14 1114 2.63e-05 0.0006307
194 REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 5 100 2.643e-05 0.0006307
195 REGULATION OF GLUCOSE TRANSPORT 5 100 2.643e-05 0.0006307
196 MOVEMENT OF CELL OR SUBCELLULAR COMPONENT 15 1275 2.792e-05 0.0006628
197 NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE 4 52 3.281e-05 0.000775
198 GLYCEROLIPID METABOLIC PROCESS 8 356 3.363e-05 0.0007904
199 CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND 9 465 3.399e-05 0.0007909
200 HOMEOSTASIS OF NUMBER OF CELLS 6 175 3.396e-05 0.0007909
201 MAMMARY GLAND EPITHELIUM DEVELOPMENT 4 53 3.54e-05 0.0008194
202 PHOSPHOLIPID METABOLIC PROCESS 8 364 3.937e-05 0.0009023
203 POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 13 1004 3.929e-05 0.0009023
204 RESPONSE TO GROWTH FACTOR 9 475 4.011e-05 0.0009149
205 REGULATION OF HYDROLASE ACTIVITY 15 1327 4.434e-05 0.001006
206 RESPONSE TO LEPTIN 3 20 4.485e-05 0.001013
207 CHEMICAL HOMEOSTASIS 12 874 4.62e-05 0.001039
208 POSITIVE REGULATION OF INFLAMMATORY RESPONSE 5 113 4.758e-05 0.001064
209 INNATE IMMUNE RESPONSE 10 619 5.586e-05 0.001244
210 MAMMARY GLAND DEVELOPMENT 5 117 5.618e-05 0.001245
211 POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 4 60 5.787e-05 0.00127
212 LEUKOCYTE HOMEOSTASIS 4 60 5.787e-05 0.00127
213 REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION 5 118 5.851e-05 0.001278
214 REGULATION OF PHOSPHOLIPID METABOLIC PROCESS 4 61 6.177e-05 0.001343
215 REGULATION OF BODY FLUID LEVELS 9 506 6.533e-05 0.001414
216 REGULATION OF DEVELOPMENTAL GROWTH 7 289 6.736e-05 0.001451
217 REGULATION OF EPITHELIAL CELL DIFFERENTIATION 5 122 6.858e-05 0.00147
218 REGULATION OF METANEPHROS DEVELOPMENT 3 23 6.915e-05 0.001476
219 GLAND DEVELOPMENT 8 395 6.99e-05 0.001485
220 POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 7 296 7.826e-05 0.001655
221 RESPONSE TO UV 5 126 7.993e-05 0.001683
222 CELLULAR RESPONSE TO UV 4 66 8.419e-05 0.001765
223 POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 5 129 8.935e-05 0.001864
224 GROWTH 8 410 9.06e-05 0.001882
225 ORGAN GROWTH 4 68 9.463e-05 0.001957
226 EPITHELIUM DEVELOPMENT 12 945 9.761e-05 0.00201
227 REGULATION OF T HELPER CELL DIFFERENTIATION 3 26 0.0001008 0.002065
228 POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION 4 70 0.000106 0.002154
229 LIPID BIOSYNTHETIC PROCESS 9 539 0.0001058 0.002154
230 REGULATION OF IMMUNE EFFECTOR PROCESS 8 424 0.0001143 0.002312
231 ENERGY RESERVE METABOLIC PROCESS 4 72 0.0001183 0.00238
232 CELLULAR RESPONSE TO RADIATION 5 137 0.0001187 0.00238
233 NEGATIVE REGULATION OF MAP KINASE ACTIVITY 4 73 0.0001248 0.002472
234 POSITIVE REGULATION OF BIOSYNTHETIC PROCESS 17 1805 0.0001238 0.002472
235 ACUTE INFLAMMATORY RESPONSE 4 73 0.0001248 0.002472
236 POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE 3 28 0.0001263 0.00248
237 POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION 3 28 0.0001263 0.00248
238 RESPONSE TO MOLECULE OF BACTERIAL ORIGIN 7 321 0.0001296 0.002533
239 VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 4 74 0.0001316 0.002562
240 CELLULAR GLUCOSE HOMEOSTASIS 4 75 0.0001387 0.002688
241 FC EPSILON RECEPTOR SIGNALING PATHWAY 5 142 0.0001404 0.002712
242 T CELL RECEPTOR SIGNALING PATHWAY 5 146 0.00016 0.003075
243 LIPID METABOLIC PROCESS 13 1158 0.0001665 0.003188
244 RESPONSE TO INTERLEUKIN 4 3 31 0.000172 0.003267
245 ORGANOPHOSPHATE BIOSYNTHETIC PROCESS 8 450 0.0001718 0.003267
246 REGULATION OF ERK1 AND ERK2 CASCADE 6 238 0.0001851 0.003501
247 TISSUE DEVELOPMENT 15 1518 0.0002005 0.003778
248 FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 4 84 0.000215 0.004033
249 REGULATION OF LEUKOCYTE MEDIATED IMMUNITY 5 156 0.0002178 0.004054
250 POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS 5 156 0.0002178 0.004054
251 BIOLOGICAL ADHESION 12 1032 0.0002223 0.004122
252 REGULATION OF PROTEIN DEACETYLATION 3 34 0.0002273 0.00418
253 PROTEIN KINASE B SIGNALING 3 34 0.0002273 0.00418
254 POSITIVE REGULATION OF MAPK CASCADE 8 470 0.0002309 0.004217
255 HORMONE MEDIATED SIGNALING PATHWAY 5 158 0.0002311 0.004217
256 POSITIVE REGULATION OF B CELL ACTIVATION 4 86 0.0002354 0.004278
257 REGENERATION 5 161 0.0002521 0.004565
258 POSITIVE REGULATION OF RESPONSE TO WOUNDING 5 162 0.0002595 0.004679
259 EPITHELIAL CELL PROLIFERATION 4 89 0.0002685 0.004823
260 T CELL SELECTION 3 36 0.0002699 0.00483
261 DEFENSE RESPONSE TO VIRUS 5 164 0.0002746 0.004895
262 POSITIVE REGULATION OF DEFENSE RESPONSE 7 364 0.0002797 0.004967
263 CELLULAR RESPONSE TO LIGHT STIMULUS 4 91 0.0002923 0.005163
264 REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION 3 37 0.0002929 0.005163
265 MORPHOGENESIS OF A BRANCHING STRUCTURE 5 167 0.0002986 0.005242
266 CELLULAR LIPID METABOLIC PROCESS 11 913 0.0003097 0.005417
267 REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION 3 38 0.0003173 0.005488
268 REGULATION OF MULTICELLULAR ORGANISMAL METABOLIC PROCESS 3 38 0.0003173 0.005488
269 CELLULAR RESPONSE TO ABIOTIC STIMULUS 6 263 0.0003167 0.005488
270 NEGATIVE REGULATION OF NEURON DEATH 5 171 0.0003329 0.005738
271 ERBB2 SIGNALING PATHWAY 3 39 0.0003428 0.005822
272 REGULATION OF CARBOHYDRATE METABOLIC PROCESS 5 172 0.000342 0.005822
273 ASTROCYTE DIFFERENTIATION 3 39 0.0003428 0.005822
274 EMBRYO IMPLANTATION 3 39 0.0003428 0.005822
275 FC GAMMA RECEPTOR SIGNALING PATHWAY 4 95 0.0003446 0.00583
276 REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 16 1784 0.0003574 0.006026
277 REGULATION OF ACTIVATED T CELL PROLIFERATION 3 40 0.0003697 0.006197
278 GLIOGENESIS 5 175 0.0003702 0.006197
279 REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY 4 97 0.0003731 0.006222
280 POSITIVE REGULATION OF TRANSPORT 11 936 0.0003827 0.006359
281 LACTATION 3 41 0.0003979 0.006589
282 MYELOID LEUKOCYTE MIGRATION 4 99 0.0004032 0.006653
283 REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE 4 101 0.000435 0.007152
284 REGULATION OF LIPID METABOLIC PROCESS 6 282 0.0004587 0.007436
285 REGULATION OF GLYCOPROTEIN METABOLIC PROCESS 3 43 0.0004583 0.007436
286 MYELOID LEUKOCYTE MEDIATED IMMUNITY 3 43 0.0004583 0.007436
287 BETA CATENIN TCF COMPLEX ASSEMBLY 3 43 0.0004583 0.007436
288 NEGATIVE REGULATION OF HYDROLASE ACTIVITY 7 397 0.0004711 0.00761
289 POSITIVE REGULATION OF PROTEIN IMPORT 4 104 0.0004861 0.007826
290 RESPONSE TO BACTERIUM 8 528 0.0005021 0.008056
291 LUNG MORPHOGENESIS 3 45 0.0005244 0.008385
292 REGULATION OF GTPASE ACTIVITY 9 673 0.0005454 0.008691
293 REPRODUCTIVE SYSTEM DEVELOPMENT 7 408 0.0005541 0.0088
294 REGULATION OF ALPHA BETA T CELL DIFFERENTIATION 3 46 0.0005596 0.008826
295 POSITIVE REGULATION OF CELL DIFFERENTIATION 10 823 0.0005582 0.008826
296 REGULATION OF INFLAMMATORY RESPONSE 6 294 0.0005712 0.008979
297 REGULATION OF IMMUNOGLOBULIN PRODUCTION 3 47 0.0005962 0.009278
298 RESPONSE TO RADIATION 7 413 0.0005956 0.009278
299 RESPONSE TO ANTIBIOTIC 3 47 0.0005962 0.009278
300 ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY 5 195 0.0006063 0.009403
301 REGULATION OF TYPE I INTERFERON PRODUCTION 4 111 0.0006216 0.009609
302 POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT1 PROTEIN 2 11 0.0006507 0.009831
303 OXALOACETATE METABOLIC PROCESS 2 11 0.0006507 0.009831
304 CREATINE METABOLIC PROCESS 2 11 0.0006507 0.009831
305 NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 2 11 0.0006507 0.009831
306 CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT 2 11 0.0006507 0.009831
307 REGULATION OF OSTEOBLAST DIFFERENTIATION 4 112 0.0006429 0.009831
308 POSITIVE REGULATION OF PROTEIN SUMOYLATION 2 11 0.0006507 0.009831
309 ORGAN MORPHOGENESIS 10 841 0.0006601 0.00994
NumGOOverlapSizeP ValueAdj. P Value
1 CYTOKINE RECEPTOR ACTIVITY 20 89 1.275e-31 1.184e-28
2 KINASE REGULATOR ACTIVITY 15 186 8.78e-17 4.078e-14
3 CYTOKINE RECEPTOR BINDING 15 271 2.397e-14 7.423e-12
4 RECEPTOR BINDING 27 1476 1.773e-13 4.118e-11
5 SIGNAL TRANSDUCER ACTIVITY 28 1731 1.092e-12 2.028e-10
6 KINASE INHIBITOR ACTIVITY 9 89 2.355e-11 3.126e-09
7 KINASE BINDING 17 606 2.17e-11 3.126e-09
8 CYTOKINE BINDING 9 92 3.192e-11 3.707e-09
9 ENZYME BINDING 26 1737 5.492e-11 5.669e-09
10 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 8 70 1.184e-10 1.1e-08
11 X1 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 7 43 1.379e-10 1.164e-08
12 PHOSPHATIDYLINOSITOL KINASE ACTIVITY 7 51 4.845e-10 3.751e-08
13 MOLECULAR FUNCTION REGULATOR 22 1353 5.761e-10 4.117e-08
14 KINASE ACTIVITY 17 842 3.375e-09 2.239e-07
15 ENZYME REGULATOR ACTIVITY 17 959 2.321e-08 1.437e-06
16 SIGNALING RECEPTOR ACTIVITY 20 1393 3.526e-08 2.047e-06
17 TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS 17 992 3.803e-08 2.078e-06
18 INSULIN RECEPTOR SUBSTRATE BINDING 4 11 4.457e-08 2.3e-06
19 PHOSPHATASE BINDING 8 162 9.604e-08 4.696e-06
20 HORMONE RECEPTOR BINDING 8 168 1.272e-07 5.907e-06
21 PROTEIN PHOSPHATASE BINDING 7 120 2.058e-07 9.102e-06
22 RECEPTOR ACTIVITY 20 1649 5.486e-07 2.317e-05
23 GROWTH FACTOR BINDING 6 123 4.55e-06 0.0001838
24 ENZYME INHIBITOR ACTIVITY 9 378 6.583e-06 0.0002548
25 STEROID HORMONE RECEPTOR BINDING 5 81 9.47e-06 0.0003519
26 GLUCOCORTICOID RECEPTOR BINDING 3 14 1.454e-05 0.0005195
27 SUMO TRANSFERASE ACTIVITY 3 15 1.813e-05 0.0006014
28 INSULIN LIKE GROWTH FACTOR RECEPTOR BINDING 3 15 1.813e-05 0.0006014
29 PHOSPHATIDYLINOSITOL PHOSPHATE KINASE ACTIVITY 3 16 2.225e-05 0.0007129
30 RNA POLYMERASE II CORE PROMOTER SEQUENCE SPECIFIC DNA BINDING 4 53 3.54e-05 0.001096
31 PROTEIN DIMERIZATION ACTIVITY 14 1149 3.698e-05 0.001108
32 PROTEIN KINASE ACTIVITY 10 640 7.376e-05 0.002141
33 TRANSCRIPTION FACTOR BINDING 9 524 8.535e-05 0.002403
34 GROWTH FACTOR RECEPTOR BINDING 5 129 8.935e-05 0.002441
35 PROTEIN SERINE THREONINE KINASE INHIBITOR ACTIVITY 3 30 0.0001558 0.004135
36 CORE PROMOTER BINDING 5 152 0.000193 0.004981
37 PEPTIDE HORMONE BINDING 3 36 0.0002699 0.006776
38 ANDROGEN RECEPTOR BINDING 3 39 0.0003428 0.008381
NumGOOverlapSizeP ValueAdj. P Value
1 PHOSPHATIDYLINOSITOL 3 KINASE COMPLEX 7 20 3.534e-13 2.064e-10
2 TRANSFERASE COMPLEX TRANSFERRING PHOSPHORUS CONTAINING GROUPS 10 237 9.616e-09 2.525e-06
3 RECEPTOR COMPLEX 11 327 1.729e-08 2.525e-06
4 EXTRINSIC COMPONENT OF MEMBRANE 10 252 1.725e-08 2.525e-06
5 PLASMA MEMBRANE RECEPTOR COMPLEX 8 175 1.741e-07 2.033e-05
6 MEMBRANE PROTEIN COMPLEX 16 1020 3.429e-07 3.338e-05
7 TRANSFERASE COMPLEX 12 703 5.314e-06 0.0004434
8 INTRINSIC COMPONENT OF PLASMA MEMBRANE 17 1649 4.015e-05 0.002931
9 PLASMA MEMBRANE PROTEIN COMPLEX 9 510 6.94e-05 0.004503

Over-represented Pathway

NumPathwayPathviewOverlapSizeP ValueAdj. P Value
1 hsa04630_Jak.STAT_signaling_pathway 70 155 1.625e-156 2.925e-154
2 hsa04151_PI3K_AKT_signaling_pathway 25 351 1.714e-26 1.542e-24
3 hsa04380_Osteoclast_differentiation 18 128 1.649e-24 9.895e-23
4 hsa04910_Insulin_signaling_pathway 16 138 1.953e-20 8.79e-19
5 hsa04012_ErbB_signaling_pathway 14 87 4.614e-20 1.661e-18
6 hsa04062_Chemokine_signaling_pathway 16 189 3.376e-18 1.013e-16
7 hsa04650_Natural_killer_cell_mediated_cytotoxicity 13 136 1.264e-15 2.98e-14
8 hsa04620_Toll.like_receptor_signaling_pathway 12 102 1.324e-15 2.98e-14
9 hsa04662_B_cell_receptor_signaling_pathway 11 75 1.741e-15 3.483e-14
10 hsa04660_T_cell_receptor_signaling_pathway 12 108 2.69e-15 4.842e-14
11 hsa04664_Fc_epsilon_RI_signaling_pathway 11 79 3.178e-15 5.201e-14
12 hsa04510_Focal_adhesion 14 200 7.476e-15 1.121e-13
13 hsa04210_Apoptosis 11 89 1.25e-14 1.731e-13
14 hsa04722_Neurotrophin_signaling_pathway 12 127 1.971e-14 2.534e-13
15 hsa04973_Carbohydrate_digestion_and_absorption 9 44 2.973e-14 3.568e-13
16 hsa04150_mTOR_signaling_pathway 9 52 1.509e-13 1.698e-12
17 hsa04370_VEGF_signaling_pathway 9 76 5.471e-12 5.793e-11
18 hsa04914_Progesterone.mediated_oocyte_maturation 9 87 1.911e-11 1.911e-10
19 hsa04014_Ras_signaling_pathway 12 236 3.204e-11 3.035e-10
20 hsa04666_Fc_gamma_R.mediated_phagocytosis 9 95 4.282e-11 3.854e-10
21 hsa04960_Aldosterone.regulated_sodium_reabsorption 7 42 1.157e-10 9.92e-10
22 hsa04670_Leukocyte_transendothelial_migration 8 117 7.514e-09 6.148e-08
23 hsa04070_Phosphatidylinositol_signaling_system 7 78 1.026e-08 8.03e-08
24 hsa04810_Regulation_of_actin_cytoskeleton 9 214 5.742e-08 4.307e-07
25 hsa04920_Adipocytokine_signaling_pathway 6 68 1.363e-07 9.812e-07
26 hsa04110_Cell_cycle 6 128 5.728e-06 3.965e-05
27 hsa04120_Ubiquitin_mediated_proteolysis 6 139 9.201e-06 6.134e-05
28 hsa04310_Wnt_signaling_pathway 6 151 1.476e-05 9.49e-05
29 hsa04640_Hematopoietic_cell_lineage 4 88 0.0002571 0.001596
30 hsa00562_Inositol_phosphate_metabolism 3 57 0.001049 0.006296
31 hsa04115_p53_signaling_pathway 3 69 0.001823 0.01059
32 hsa04390_Hippo_signaling_pathway 4 154 0.00209 0.01175
33 hsa04010_MAPK_signaling_pathway 5 268 0.002478 0.01352
34 hsa04350_TGF.beta_signaling_pathway 3 85 0.003303 0.01749
35 hsa04320_Dorso.ventral_axis_formation 2 25 0.003439 0.01769
36 hsa04330_Notch_signaling_pathway 2 47 0.01179 0.05897
37 hsa04672_Intestinal_immune_network_for_IgA_production 2 49 0.01277 0.06213
38 hsa04720_Long.term_potentiation 2 70 0.02502 0.1185
39 hsa04520_Adherens_junction 2 73 0.02705 0.1248
40 hsa04540_Gap_junction 2 90 0.03969 0.1786
41 hsa04912_GnRH_signaling_pathway 2 101 0.04885 0.2093
42 hsa04916_Melanogenesis 2 101 0.04885 0.2093
43 hsa04530_Tight_junction 2 133 0.07913 0.3312
44 hsa04144_Endocytosis 2 203 0.1588 0.6495

lncRNA-mediated sponge

(Download full result)

Num lncRNA miRNAs           miRNAs count     Gene Sponge regulatory network lncRNA log2FC lncRNA pvalue Gene log2FC Gene pvalue lncRNA-gene Pearson correlation
1

DHRS4-AS1

 hsa-miR-1301-3p;hsa-miR-148b-5p;hsa-miR-17-5p;hsa-miR-181b-5p;hsa-miR-19a-3p;hsa-miR-21-5p;hsa-miR-301a-3p;hsa-miR-362-5p;hsa-miR-501-5p;hsa-miR-589-3p;hsa-miR-93-3p 11 IL6ST Sponge network -0.646 0.01829 -1.919 0 0.587
2

HCG11

 hsa-miR-106b-5p;hsa-miR-107;hsa-miR-15a-5p;hsa-miR-17-3p;hsa-miR-17-5p;hsa-miR-20a-5p;hsa-miR-33a-3p;hsa-miR-362-3p;hsa-miR-502-3p;hsa-miR-93-5p 10 AKT3 Sponge network -0.781 0 -0.659 0.00047 0.574
3

DHRS4-AS1

 hsa-miR-106b-5p;hsa-miR-1301-3p;hsa-miR-132-3p;hsa-miR-17-5p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-582-5p;hsa-miR-589-3p 10 PIK3R1 Sponge network -0.646 0.01829 -0.892 0 0.557
4 LINC00261 hsa-miR-106b-5p;hsa-miR-1301-3p;hsa-miR-132-3p;hsa-miR-188-5p;hsa-miR-21-5p;hsa-miR-212-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-324-3p;hsa-miR-330-3p;hsa-miR-629-3p 11 PIK3R1 Sponge network -1.194 0 -0.892 0 0.513
5

RP11-12A2.3

 hsa-miR-103a-3p;hsa-miR-106b-5p;hsa-miR-1301-3p;hsa-miR-132-3p;hsa-miR-17-5p;hsa-miR-188-5p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-93-5p 12 PIK3R1 Sponge network -4.779 0 -0.892 0 0.489
6 LINC01018 hsa-miR-103a-3p;hsa-miR-106b-5p;hsa-miR-1301-3p;hsa-miR-132-3p;hsa-miR-17-5p;hsa-miR-200c-3p;hsa-miR-21-5p;hsa-miR-212-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-324-3p;hsa-miR-338-5p;hsa-miR-589-3p;hsa-miR-629-3p;hsa-miR-93-5p 15 PIK3R1 Sponge network -3.231 0 -0.892 0 0.472
7

LDLRAD4-AS1

 hsa-miR-103a-3p;hsa-miR-106b-5p;hsa-miR-1301-3p;hsa-miR-132-3p;hsa-miR-17-5p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-93-5p 10 PIK3R1 Sponge network -3.366 0 -0.892 0 0.45
8 RP11-119D9.1 hsa-miR-106b-5p;hsa-miR-1301-3p;hsa-miR-132-3p;hsa-miR-188-5p;hsa-miR-200c-3p;hsa-miR-21-5p;hsa-miR-212-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-629-3p;hsa-miR-93-5p 11 PIK3R1 Sponge network -2.765 0 -0.892 0 0.418
9 RP11-290F5.1 hsa-miR-103a-3p;hsa-miR-106b-5p;hsa-miR-1301-3p;hsa-miR-132-3p;hsa-miR-17-5p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-212-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-324-3p 11 PIK3R1 Sponge network -1.679 5.0E-5 -0.892 0 0.402
10

RP11-12A2.3

 hsa-miR-103a-3p;hsa-miR-1301-3p;hsa-miR-148b-5p;hsa-miR-17-5p;hsa-miR-181b-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-21-5p;hsa-miR-301a-3p;hsa-miR-93-3p 10 IL6ST Sponge network -4.779 0 -1.919 0 0.381
11

HCG11

 hsa-miR-103a-3p;hsa-miR-130b-3p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-21-5p;hsa-miR-301a-3p;hsa-miR-362-3p;hsa-miR-421;hsa-miR-455-5p 11 IL6ST Sponge network -0.781 0 -1.919 0 0.38
12 ALDH1L1-AS2 hsa-let-7e-5p;hsa-let-7i-5p;hsa-miR-125a-5p;hsa-miR-141-3p;hsa-miR-141-5p;hsa-miR-182-5p;hsa-miR-200a-3p;hsa-miR-21-5p;hsa-miR-23a-3p;hsa-miR-301a-3p 10 IL6R Sponge network 0.116 0.79006 -0.197 0.38255 0.373
13 LINC00238 hsa-miR-106b-5p;hsa-miR-1301-3p;hsa-miR-132-3p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-188-5p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-212-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-629-3p 12 PIK3R1 Sponge network -4.997 0 -0.892 0 0.369
14

MAGI2-AS3

 hsa-miR-106b-5p;hsa-miR-1266-5p;hsa-miR-15b-5p;hsa-miR-17-5p;hsa-miR-19a-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-589-3p;hsa-miR-616-5p;hsa-miR-9-5p;hsa-miR-92a-3p;hsa-miR-93-5p 13 CCND1 Sponge network -1.801 0 -0.902 1.0E-5 0.359
15 AC004862.6 hsa-miR-106b-5p;hsa-miR-1301-3p;hsa-miR-132-3p;hsa-miR-17-5p;hsa-miR-188-5p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-212-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-629-3p;hsa-miR-93-5p 12 PIK3R1 Sponge network -2.202 0.00081 -0.892 0 0.357
16 RP11-407B7.1 hsa-miR-1301-3p;hsa-miR-132-3p;hsa-miR-21-5p;hsa-miR-212-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-324-3p;hsa-miR-338-5p;hsa-miR-629-3p;hsa-miR-93-5p 10 PIK3R1 Sponge network -0.818 0.00584 -0.892 0 0.324
17

RP11-166D19.1

 hsa-miR-106b-5p;hsa-miR-1301-3p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-188-5p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-324-3p;hsa-miR-589-3p;hsa-miR-590-5p;hsa-miR-629-3p 11 PIK3R1 Sponge network -0.244 0.28835 -0.892 0 0.32
18

MAGI2-AS3

 hsa-miR-103a-3p;hsa-miR-1301-3p;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-21-5p;hsa-miR-301a-3p;hsa-miR-362-3p;hsa-miR-452-5p;hsa-miR-501-5p;hsa-miR-532-5p;hsa-miR-589-3p;hsa-miR-766-3p;hsa-miR-93-3p 15 IL6ST Sponge network -1.801 0 -1.919 0 0.318
19 RP11-7F17.3 hsa-miR-103a-3p;hsa-miR-106b-5p;hsa-miR-1301-3p;hsa-miR-132-3p;hsa-miR-17-5p;hsa-miR-188-5p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-324-3p 11 PIK3R1 Sponge network -0.873 0.00204 -0.892 0 0.271
20

SMIM2-AS1

 hsa-miR-103a-3p;hsa-miR-106b-5p;hsa-miR-1301-3p;hsa-miR-132-3p;hsa-miR-17-5p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-212-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-629-3p 12 PIK3R1 Sponge network -0.66 0.00587 -0.892 0 0.27
21

SMIM2-AS1

 hsa-let-7e-5p;hsa-let-7i-5p;hsa-miR-125a-5p;hsa-miR-155-5p;hsa-miR-182-5p;hsa-miR-21-5p;hsa-miR-23a-3p;hsa-miR-301a-3p;hsa-miR-331-3p;hsa-miR-501-5p 10 IL6R Sponge network -0.66 0.00587 -0.197 0.38255 0.261
22

RP11-166D19.1

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-1266-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-5p;hsa-miR-186-5p;hsa-miR-19a-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-425-5p;hsa-miR-589-3p;hsa-miR-616-5p;hsa-miR-92a-3p;hsa-miR-942-5p 16 CCND1 Sponge network -0.244 0.28835 -0.902 1.0E-5 0.253

Quest ID: cc122a7d178bc9a6daf3811204156990